UK markets open in 3 hours 40 minutes

Caribou Biosciences, Inc. (CRBU)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.1300-0.2600 (-7.67%)
At close: 04:00PM EDT
3.1300 0.00 (0.00%)
After hours: 07:39PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 306.18M
Enterprise value 39.35M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.20
Price/book (mrq)0.89
Enterprise value/revenue 1.18
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.56
52-week change 3-36.51%
S&P500 52-week change 328.04%
52-week high 38.5900
52-week low 33.0100
50-day moving average 34.3581
200-day moving average 35.3401

Share statistics

Avg vol (3-month) 31.8M
Avg vol (10-day) 32.43M
Shares outstanding 590.32M
Implied shares outstanding 690.32M
Float 869.03M
% held by insiders 110.06%
% held by institutions 176.88%
Shares short (30 Apr 2024) 410.64M
Short ratio (30 Apr 2024) 46.6
Short % of float (30 Apr 2024) 412.34%
Short % of shares outstanding (30 Apr 2024) 411.78%
Shares short (prior month 28 Mar 2024) 410.2M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,893.87%

Management effectiveness

Return on assets (ttm)-21.70%
Return on equity (ttm)-37.09%

Income statement

Revenue (ttm)33.4M
Revenue per share (ttm)0.41
Quarterly revenue growth (yoy)-30.60%
Gross profit (ttm)N/A
EBITDA -127.3M
Net income avi to common (ttm)-115.26M
Diluted EPS (ttm)-1.3800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)293.99M
Total cash per share (mrq)3.26
Total debt (mrq)27.16M
Total debt/equity (mrq)7.91%
Current ratio (mrq)10.49
Book value per share (mrq)3.80

Cash flow statement

Operating cash flow (ttm)-102.56M
Levered free cash flow (ttm)-74.01M